x
Filter:
Filters applied
- Neurobiology
- Peshenko, Igor VRemove Peshenko, Igor V filter
- signal transductionRemove signal transduction filter
Publication Date
Please choose a date range between 2016 and 2021.
Keyword
- guanylate cyclase (guanylyl cyclase)3
- photoreceptor3
- calcium-binding proteins2
- cyclic GMP (cGMP)2
- GCAP2
- phototransduction2
- RD32
- RetGC2
- retina2
- retinal degeneration2
- calcium-binding protein1
- cGMP phosphodiesterase 61
- congenital blindness1
- cyclic GMP1
- electroretinography1
- ERG1
- eye1
- GMP1
- guanylyl cyclase activating protein1
- LCA121
- Leber's congenital amaurosis-121
- neurobiology1
- PDE61
- PEI1
Neurobiology
3 Results
- Research ArticleOpen Access
Retinal degeneration-3 protein promotes photoreceptor survival by suppressing activation of guanylyl cyclase rather than accelerating GMP recycling
Journal of Biological ChemistryVol. 296100362Published online: February 1, 2021- Alexander M. Dizhoor
- Elena V. Olshevskaya
- Igor V. Peshenko
Cited in Scopus: 3Retinal degeneration-3 protein (RD3) deficiency causes photoreceptor dysfunction and rapid degeneration in the rd3 mouse strain and in human Leber’s congenital amaurosis, a congenital retinal dystrophy that results in early vision loss. However, the mechanisms responsible for photoreceptor death remain unclear. Here, we tested two hypothesized biochemical events that may underlie photoreceptor death: (i) the failure to prevent aberrant activation of retinal guanylyl cyclase (RetGC) by calcium-sensor proteins (GCAPs) versus (ii) the reduction of GMP phosphorylation rate, preventing its recycling to GDP/GTP. - Signal TransductionOpen Access
Two clusters of surface-exposed amino acid residues enable high-affinity binding of retinal degeneration-3 (RD3) protein to retinal guanylyl cyclase
Journal of Biological ChemistryVol. 295Issue 31p10781–10793Published online: June 3, 2020- Igor V. Peshenko
- Alexander M. Dizhoor
Cited in Scopus: 4Retinal degeneration-3 (RD3) protein protects photoreceptors from degeneration by preventing retinal guanylyl cyclase (RetGC) activation via calcium-sensing guanylyl cyclase–activating proteins (GCAP), and RD3 truncation causes severe congenital blindness in humans and other animals. The three-dimensional structure of RD3 has recently been established, but the molecular mechanisms of its inhibitory binding to RetGC remain unclear. Here, we report the results of probing 133 surface-exposed residues in RD3 by single substitutions and deletions to identify side chains that are critical for the inhibitory binding of RD3 to RetGC. - NeurobiologyOpen Access
Functional Study and Mapping Sites for Interaction with the Target Enzyme in Retinal Degeneration 3 (RD3) Protein
Journal of Biological ChemistryVol. 291Issue 37p19713–19723Published online: July 28, 2016- Igor V. Peshenko
- Elena V. Olshevskaya
- Alexander M. Dizhoor
Cited in Scopus: 24Retinal degeneration 3 (RD3) protein, essential for normal expression of retinal membrane guanylyl cyclase (RetGC) in photoreceptor cells, blocks RetGC catalytic activity and stimulation by guanylyl cyclase-activating proteins (GCAPs). In a mouse retina, RD3 inhibited both RetGC1 and RetGC2 isozymes. Photoreceptors in the rd3/rd3 mouse retinas lacking functional RD3 degenerated more severely than in the retinas lacking both RetGC isozymes, consistent with a hypothesis that the inhibitory activity of RD3 has a functional role in photoreceptors.